Michael Snyder, PhD

Healthcare generally continues treat illness rather than preserve and promote health. Dr. Snyder has chosen to use data and remote monitoring approaches to monitor people while they are healthy and to detect disease at its earliest moment, before they have symptoms. By using advanced multi-"omics" technologies -- genomics, immunomics, transcriptomics, proteomics, metabolomics, microbiomics -- as well as wearables and microsampling, health can be monitored actively. 

He presents information on a group of 109 individuals for over 13 years, revealing numerous major health discoveries in cardiovascular disease, oncology, metabolic health, and infectious disease. His lab has identified distinct aging pattersn that can be measured within actionable periods of time. These wearble devices are now being used for early detection of infectious diseases and microsampling to monitor and improve lifestyle to transform healthcare by preserving health and prevent disease in real time

Biography:

As a pioneer of Precision Medicine, Dr Michael Snyder has invented many technologies enabling the 21st century of healthcare including systems biology, RNA sequencing, and protein chip. Dr Snyder has initiated the Big Data approach to healthcare through his work using omics to detect early stage disease, including wearables to detect infectious diseases like COVID-19, and at-home microsampling to measure hundreds of molecules from a single drop of blood. He is the first researcher to gather petabytes of data on individuals, which is 1 Million - 1 trillion times more data than the average clinician collects. He as published over 900 papers and is one of the most cited scientists. In terms of commercial success, Mike has co-founded 17 companies (including 2 unicorns) with combined enterprise value of over $6 billion.